China's Tigermed to Help AstraZeneca Get New Drugs to Market
Tang Shihua
DATE:  Jul 08 2019
/ SOURCE:  yicai
China's Tigermed to Help AstraZeneca Get New Drugs to Market China's Tigermed to Help AstraZeneca Get New Drugs to Market

(Yicai Global) July 8 -- China's Tigermed Consulting will deepen collaboration with a unit of multinational drugmaker AstraZeneca to conduct clinical research for the latter.

Tigermed and AstraZeneca Investment China penned a cooperation agreement under which the former will provide services including quality control and registration assistance regarding new drugs, as well as clinical monitoring, medical imaging, data management, cold chain logistics and personnel training for the latter, the Hangzhou-based contract research organization said in a statement, without disclosing financial details.

Founded in 2004, Tigermed is already a preferred service supplier for the subsidiary of the Cambridge-headquartered firm that focuses on oncology, cardiovascular, metabolic and respiratory disease treatments.

Editor: Emmi Laine 

Follow Yicai Global on
Keywords:   AstraZeneca Investment China,Tigermed Consulting,Clinical Trial Services